Help
Subscribe


GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy

 14 December 2017

Advanced search
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy Profile of Roy Pounder

Home

News  
Journals
Review Articles
Slide Atlas
Video Clips
Online Books
Advanced Digestive Endoscopy
Classical Cases
Conference Diary
PubMed
International GH Links
USA GH Links
National GH Links
National GI Societies
Other Useful Links




Emails on Gastroenterology and Hepatology
the National AIDS Treatment Advocacy Project
Visit the gastroenterology section of the EUMS

News

Genetic variant associated with liver cancer after HCV eradication

A genome-wide association study reported in May's issue of Gastroenterology identifies TLL1 variant associated with development of hepatocellular carcinoma after eradication of Hepatitis C virus infection.

News image

There is still a risk for hepatocellular carcinoma development after eradication of hepatitis C virus (HCV) infection with antiviral agents. 

Dr Yasuhito Tanaka and colleagues from Japan investigated genetic factors associated with the development of hepatocellular carcinoma in patients with a sustained virologic response to treatment for chronic HCV infection.

The research team obtained genomic DNA from 457 patients in Japan with a sustained virological response to interferon-based treatment for chronic HCV infection from 2007 through 2015. 

The team conducted a genome-wide association study, followed by a replication analysis of 79 candidate single nucleotide polymorphisms in an independent set of 486 patients in Japan. 

Levels of TLL1 mRNA increased in liver tissues of patients with progression of fibrosis
Gastroenterology
The study end point was hepatocellular carcinoma diagnosis or confirmation of lack of hepatocellular carcinoma. 

The team collected clinical and laboratory data from all patients. 

The researchers analyzed expression levels of candidate gene variants in human hepatic stellate cells, rats with steatohepatitis caused by a choline-deficient L-amino acid-defined diet, and a mouse model of liver injury caused by administration of carbon tetrachloride. 

The team also analyzed expression levels in liver tissues of patients with chronic HCV infection with different stages of fibrosis or tumors vs patients without HCV infection (controls).

The research team found a strong association between the single nucleotide polymorphism rs17047200, located within the intron of the tolloid like 1 gene (TLL1) on chromosome 4, and development of hepatocellular carcinoma.

There was a genome-wide level of significance when the results of the genome-wide association study, and replication study were combined. 

The team showed rs17047200 AT/TT to be an independent risk factor for hepatocellular carcinoma, along with male sex, older age, lower level of albumin, advanced stage of hepatic fibrosis, presence of diabetes, and higher post-treatment level of α-fetoprotein. 

Combining the rs17047200 genotype with other factors, the researchers developed prediction models for hepatocellular carcinoma development in patients with mild or advanced hepatic fibrosis. 

Levels of TII1 messenger RNA (mRNA) in human hepatic stellate cells increased with activation. 

Levels of TLL1 mRNA increased in liver tissues of rodents with hepatic fibrogenesis compared with controls. 

The research team found that levels of TLL1 mRNA increased in liver tissues of patients with progression of fibrosis. 

Gene expression levels of TLL1 short variants, including isoform 2, were higher in patients with rs17047200 AT/TT.

Dr Tanaka's team concludes, "In a genome-wide association study, we identified the association between the single nucleotide polymorphisms rs17047200, within the intron of TLL1, and development of hepatocellular carcinoma in patients who achieved an SVR to treatment for chronic HCV infection."

"We found levels of TII1/TLL1 mRNA to be increased in rodent models of liver injury and liver tissues of patients with fibrosis, compared with controls."

"We propose that this single nucleotide polymorphism might affect splicing of TLL1 mRNA, yielding short variants with high catalytic activity that accelerates hepatic fibrogenesis and carcinogenesis."

"Further studies are needed to determine how rs17047200 affects TLL1 mRNA levels, splicing, and translation, as well as the prevalence of this variant among other patients with hepatocellular carcinoma."

"Tests for the TLL1 single nucleotide polymorphism might be used to identify patients at risk for hepatocellular carcinoma after an sustained virological response to treatment of HCV infection."

Gastroenterol 2017: 152(6): 1383–1394 
01 May 2017

Go to top of page Email this page Email this page to a colleague

 14 December 2017 
H. pylori eradication therapies in countries with clarithromycin resistance
 14 December 2017 
Reliability of the IBD index
 14 December 2017 
PPIs and gastric cancer after H.pylori eradication
 13 December 2017 
Management of abnormal liver blood tests
 13 December 2017 
Tryptophan metabolism and IBD activity
 13 December 2017 
Disease severity in NAFLD
 12 December 2017 
Risk factors in undiagnosed cirrhosis
 12 December 2017 
Monitored anesthesia care for outpatient GI endoscopy
 12 December 2017 
High-risk colorectal cancer patients
 06 December 2017 
Reflux-induced chronic cough 
 06 December 2017 
Preventing hepatic encephalopathy-related readmissions
 06 December 2017 
Systemic inflammatory response syndrome in acute-on-chronic liver failure
 05 December 2017 
Childhood obesity into adulthood
 05 December 2017 
CT imaging for acute diverticulitis
 05 December 2017 
Thiopurines and colorectal cancer in IBD
 04 December 2017 
Neoadjuvant chemoradiation for locally advanced rectal cancer
 04 December 2017 
Physical activity and Barrett’s esophagus
 04 December 2017 
Alcohol abstinence and alcoholic hepatitis
 01 December 2017 
Therapeutic drug monitoring in IBD
 01 December 2017 
Insulin therapy and liver cancer among diabetics
 01 December 2017 
Family burden of pediatric Crohn's in the USA
 30 November 2017 
Anastomotic leak after repeat intestinal resection in Crohn’s
 30 November 2017 
Oral capsule– vs colonoscopy-delivered fecal microbiota transplant
 30 November 2017 
Sessile serrated polyps and H. pylori in the USA
 29 November 2017 
Medical cannabinoid legalization policy and vomiting
 29 November 2017 
Predicting mortality after colectomy for C. diff
 29 November 2017 
Obesity and cancer risk
 28 November 2017 
Celiac disease screening in adult first-degree relatives
 28 November 2017 
Electronic health record alert in primary care in Hep C
 28 November 2017 
Surgical treatment delays and colon cancer survival
 27 November 2017 
Questionnaire fore chronic constipation
 27 November 2017 
Challenges in measuring the affordability of US health care
 27 November 2017 
Early readmission in IBD patients
 24 November 2017 
Osteoporotic fractures in Barrett's esophagus
 24 November 2017 
Center ERCP volume and procedure success
 24 November 2017 
Adipokines and IBD
 23 November 2017 
Incidence of biopsy-verified celiac disease
 23 November 2017 
Pharmacological management of GERD
 23 November 2017 
Distance travelling for rectal cancer outcomes
 22 November 2017 
Challenges of US-trained gastroenterologists when abroad
 22 November 2017 
Surgical treatment delays influence survival in colon cancer
 22 November 2017 
Golimumab in Crohn's disease
 21 November 2017 
Preoperative optimization in IBD patients
 21 November 2017 
Cholangiopathy in critically ill patients
 21 November 2017 
Prepregnancy obesity and maternal mortality
 20 November 2017 
Barriers to hepatitis C treatment
 20 November 2017 
Socioeconomic characteristics in diverticular disease
 20 November 2017 
Endoscopic indices of disease activity for Crohn’s
 17 November 2017 
Predicting microscopic colitis
 17 November 2017 
Food elimination diets for treatment of adults with eosinophilic esophagitis
 17 November 2017 
PPI use and cognitive function in women
 16 November 2017 
NAFLD-hepatocellular carcinoma and survival after orthotopic liver transplant
 16 November 2017 
Prepregnancy obesity and severe maternal morbidity
 16 November 2017 
Celiac disease screening in adult first-degree relatives
 15 November 2017 
Breastfeeding and the risk of IBD
 15 November 2017 
Predicting recurrence after curative rectal cancer surgery
 15 November 2017 
Medication nonadherence and health care costs
 14 November 2017 
Eosinophilic gastroenteritis and colitis
 14 November 2017 
HBV/HCV coinfection and cirrhosis
 14 November 2017 
Sexual dysfunction after rectal cancer surgery

Blackwell Publishing


GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors
Privacy Statement
Disclaimer
About Us